Cerebral venous sinus thrombosis

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The cerebral venous system is an unusual site of thrombosis, with a particularly high incidence in young adults. This incidence has increased in past decades because of the improvement of neuroradiological techniques. Risk factors for cerebral venous sinus thrombosis overlap with those of other venous thromboembolism sites; however, some are specific for this particular anatomical district. Prognosis is favorable in most cases if diagnosis is made rapidly and treatment is promptly initiated, even if acute complications or chronic invalidity still occur in a quarter of patients. The mainstay of treatment is anticoagulation, which is necessary in order to block clot propagation and obtain recanalization. Intracranial bleeding does not contraindicate anticoagulation. Endovascular procedures are reserved for patients with a particularly severe presentation or rapidly declining neurological symptoms despite appropriate anticoagulation, although data from clinical trials are lacking. Specifically, this review addresses the epidemiology, clinical presentation and course, risk factors, and treatment of cerebral venous sinus thrombosis, with a special focus on the pediatric population.

Original languageEnglish
Pages (from-to)1918-1931
JournalJournal of Thrombosis and Haemostasis
Volume16
Issue number10
DOIs
Publication statusPublished - 2018

Fingerprint

Intracranial Sinus Thrombosis
Venous Thrombosis
Endovascular Procedures
Incidence
Venous Thromboembolism
Young Adult
Epidemiology
Thrombosis
Therapeutics
Clinical Trials
Pediatrics
Hemorrhage
Population

Keywords

  • Anticoagulants
  • Cerebral hemorrhage
  • Intracranial thrombosis
  • Low-molecular-weight heparin
  • Sinus thrombosis
  • Venous thromboembolism

ASJC Scopus subject areas

  • Hematology

Cite this

Cerebral venous sinus thrombosis. / Capecchi, M.; Abbattista, M.; Martinelli, I.

In: Journal of Thrombosis and Haemostasis, Vol. 16, No. 10, 2018, p. 1918-1931.

Research output: Contribution to journalArticle

@article{a0af119bb5a046f5bffd347b8c230d22,
title = "Cerebral venous sinus thrombosis",
abstract = "The cerebral venous system is an unusual site of thrombosis, with a particularly high incidence in young adults. This incidence has increased in past decades because of the improvement of neuroradiological techniques. Risk factors for cerebral venous sinus thrombosis overlap with those of other venous thromboembolism sites; however, some are specific for this particular anatomical district. Prognosis is favorable in most cases if diagnosis is made rapidly and treatment is promptly initiated, even if acute complications or chronic invalidity still occur in a quarter of patients. The mainstay of treatment is anticoagulation, which is necessary in order to block clot propagation and obtain recanalization. Intracranial bleeding does not contraindicate anticoagulation. Endovascular procedures are reserved for patients with a particularly severe presentation or rapidly declining neurological symptoms despite appropriate anticoagulation, although data from clinical trials are lacking. Specifically, this review addresses the epidemiology, clinical presentation and course, risk factors, and treatment of cerebral venous sinus thrombosis, with a special focus on the pediatric population.",
keywords = "Anticoagulants, Cerebral hemorrhage, Intracranial thrombosis, Low-molecular-weight heparin, Sinus thrombosis, Venous thromboembolism",
author = "M. Capecchi and M. Abbattista and I. Martinelli",
year = "2018",
doi = "10.1111/jth.14210",
language = "English",
volume = "16",
pages = "1918--1931",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Cerebral venous sinus thrombosis

AU - Capecchi, M.

AU - Abbattista, M.

AU - Martinelli, I.

PY - 2018

Y1 - 2018

N2 - The cerebral venous system is an unusual site of thrombosis, with a particularly high incidence in young adults. This incidence has increased in past decades because of the improvement of neuroradiological techniques. Risk factors for cerebral venous sinus thrombosis overlap with those of other venous thromboembolism sites; however, some are specific for this particular anatomical district. Prognosis is favorable in most cases if diagnosis is made rapidly and treatment is promptly initiated, even if acute complications or chronic invalidity still occur in a quarter of patients. The mainstay of treatment is anticoagulation, which is necessary in order to block clot propagation and obtain recanalization. Intracranial bleeding does not contraindicate anticoagulation. Endovascular procedures are reserved for patients with a particularly severe presentation or rapidly declining neurological symptoms despite appropriate anticoagulation, although data from clinical trials are lacking. Specifically, this review addresses the epidemiology, clinical presentation and course, risk factors, and treatment of cerebral venous sinus thrombosis, with a special focus on the pediatric population.

AB - The cerebral venous system is an unusual site of thrombosis, with a particularly high incidence in young adults. This incidence has increased in past decades because of the improvement of neuroradiological techniques. Risk factors for cerebral venous sinus thrombosis overlap with those of other venous thromboembolism sites; however, some are specific for this particular anatomical district. Prognosis is favorable in most cases if diagnosis is made rapidly and treatment is promptly initiated, even if acute complications or chronic invalidity still occur in a quarter of patients. The mainstay of treatment is anticoagulation, which is necessary in order to block clot propagation and obtain recanalization. Intracranial bleeding does not contraindicate anticoagulation. Endovascular procedures are reserved for patients with a particularly severe presentation or rapidly declining neurological symptoms despite appropriate anticoagulation, although data from clinical trials are lacking. Specifically, this review addresses the epidemiology, clinical presentation and course, risk factors, and treatment of cerebral venous sinus thrombosis, with a special focus on the pediatric population.

KW - Anticoagulants

KW - Cerebral hemorrhage

KW - Intracranial thrombosis

KW - Low-molecular-weight heparin

KW - Sinus thrombosis

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=85050650522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050650522&partnerID=8YFLogxK

U2 - 10.1111/jth.14210

DO - 10.1111/jth.14210

M3 - Article

AN - SCOPUS:85050650522

VL - 16

SP - 1918

EP - 1931

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 10

ER -